Fox Chase Cancer Center

Drop in testosterone tied to prostate cancer recurrence

Men whose testosterone drops following radiation therapy for prostate cancer are more likely to experience a change in PSA levels that signals their cancer has returned, according to new research from Fox Chase Cancer Center. ...

Oct 28, 2012
popularity 3.5 / 5 (2) | comments 0

More cutting-edge cancer research supported by industry

Nearly half of the research presented at ASCO's annual meeting last year came from researchers with ties to companies, and the amount appears to be increasing every year, according to new findings from Fox Chase Cancer Center. ...

May 17, 2012
popularity not rated yet | comments 0

New compound targets key mechanism behind lymphoma

Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma. The new findings will be announced at the AACR Annual Meeting 2012 on ...

Apr 03, 2012
popularity 5 / 5 (3) | comments 0

New boost for pancreatic cancer therapy

Scientists at Fox Chase Cancer Center are developing a new way to treat pancreatic cancer by boosting the effects of gemcitabine (Gemzar)—the chemotherapy drug that is considered standard therapy for the disease. Although ...

Apr 02, 2012
popularity not rated yet | comments 0